Article
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer.
Oncogene - 30 Aug 2012
Liu W, Lindberg J, Sui G, Luo J, Egevad L, Li T, Xie C, Wan M, Kim S-T, Wang Z, Turner A R, Zhang Z, Feng J, Yan Y, Sun J, Bova G S, Ewing C M, Yan G, Gielzak M, Cramer S D, Vessella R L, Zheng S L, Grönberg H, Isaacs W B, Xu J
Abstract excerpt
A clearer definition of the molecular determinants that drive the development and progression of prostate cancer (PCa) is urgently needed. Efforts to map recurrent somatic deletions in the tumor genome, especially homozygous deletions (HODs), have provided important positional information in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
